H.B. Fuller Acquires Two Medical Adhesive Companies

H.B. Fuller reports that it has signed agreements to acquire two leading medical adhesive technology companies: GEM S.r.l. and Medifill Ltd. When combined, the two companies are expected to generate 2024 net revenue and adjusted EBITDA of €23 million and €11.5 million, respectively. They will operate within H.B. Fuller’s Hygiene, Health & Consumable (HHC) Adhesives Global Business Unit (GBU). 

Medifill Ltd. is an Irish formulator and producer of medical-grade cyanoacrylate adhesives with a state-of-the-art clean room and manufacturing capabilities. H.B. Fuller reports that Medifill produces advanced technology that is specifically tailored for the wound closure market with next-generation formulations that enable fast, safe, and effective wound closure.

GEM S.r.l. is an Italian manufacturer and provider of medical adhesives and innovative application devices approved and certified for over 80 internal indications. H.B. Fuller reports that this acquisition establishes a European headquarters for H.B. Fuller’s Medical Adhesive Technologies (MAT) business and expands the company’s medical adhesive offerings, further shifting its portfolio toward highly profitable, higher growth markets.

These acquisitions build upon the company’s previous investments in the tissue adhesives market — including the acquisition of Cyberbond in 2016, Tissue Seal in 2021, and Adhezion Biomedical in 2023 — significantly expanding its global Medical Adhesive Technologies (MAT) business and geographic footprint, according to the company.

“Tissue adhesives designed for internal use offer innovative alternatives to traditional sutures, staples and embolizing agents,” said H.B. Fuller President and CEO Celeste Mastin. “With the purchase of GEM, Medifill, and our previous acquisitions in this space, H.B. Fuller has now built a Medical Adhesive Technologies business founded on our expertise in cyanoacrylate chemistry, and we have extended our penetration into a global footprint.”

Subject to customary closing conditions and regulatory approvals, the GEM acquisition is expected to close in February 2025.

Source: H.B. Fuller Co.